GlaxoSmithKline: all 4,196 studies
Page 4 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in JapanCompletedNCT04551989Results posted
- Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab MafodotinTerminatedNCT04549363Phase 3Results posted
- Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)TerminatedNCT04544995Phase 1Results posted
- A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis BCompletedNCT04544956Phase 2Results posted
- A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically SuppressedCompletedNCT04542070Phase 3Results posted
- A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and ToddlersCompletedNCT04535037Phase 4Results posted
- Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254CompletedNCT04507321Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy ParticipantsTerminatedNCT04504435Phase 1Results posted
- Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young AdultsCompletedNCT04502693Phase 3Results posted
- Drug-drug Interaction Study of GepotidacinCompletedNCT04493931Phase 1Results posted
- GSK3739937 First-Time-In-Human (FTIH) Study in Healthy VolunteersCompletedNCT04493684Phase 1Results posted
- A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive AdultsTerminatedNCT04493216Phase 2Results posted
- Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.CompletedNCT04488770Phase 1Results posted
- Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT04484623Phase 3Results posted
- Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult ParticipantsCompletedNCT04484337Phase 1Results posted
- Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT04475939Phase 3Results posted
- A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)CompletedNCT04449029Phase 2Results posted
- Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT04428333Phase 3Results posted
- Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy AdultsCompletedNCT04425902Phase 1Results posted
- Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)CompletedNCT04420221Phase 2Results posted
- A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European CountriesCompletedNCT04399551Phase 3Results posted
- A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal FunctionActive, not recruitingNCT04398745Phase 1Results posted
- Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related DiseaseCompletedNCT04376684Phase 2Results posted
- Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult ParticipantsCompletedNCT04371380Phase 1Results posted
- A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy ParticipantsCompletedNCT04366349Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial CancerTerminatedNCT04349280Phase 1Results posted
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)TerminatedNCT04333147Phase 3Results posted
- Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of AgeCompletedNCT04318548Phase 3Results posted
- Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed ConditionsCompletedNCT04318535Phase 1Results posted
- A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis ParticipantsCompletedNCT04316585Phase 1Results posted
- Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican ParticipantsCompletedNCT04311463Phase 1Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular EdemaTerminatedNCT04292912Phase 1Results posted
- Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic AsthmaCompletedNCT04276233Phase 4Results posted
- A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy ParticipantsCompletedNCT04263142Phase 1Results posted
- Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT04246047Phase 3Results posted
- Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)CompletedNCT04187144Phase 3Results posted
- Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT04179032Phase 2Results posted
- A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)CompletedNCT04177823Phase 1Results posted
- A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune ResponseCompletedNCT04176939Phase 3Results posted
- A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)CompletedNCT04173494Phase 3Results posted
- Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Active, not recruitingNCT04162210Phase 3Results posted
- A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant WomenCompletedNCT04138056Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese ParticipantsCompletedNCT04138043Phase 1Results posted
- Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsCompletedNCT04136145Phase 1Results posted
- Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) InhibitorsCompletedNCT04134728Phase 3Results posted
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelCompletedNCT04133909Phase 3Results posted
- Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT04128696Phase 3Results posted
- A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy ParticipantsTerminatedNCT04128293Phase 1Results posted
- Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their InfantsCompletedNCT04126213Phase 2Results posted
- Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Active, not recruitingNCT04126200Phase 1/2Results posted
- A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous FluorideCompletedNCT04123665Phase 3Results posted
- Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy VolunteersTerminatedNCT04114656Phase 1Results posted
- Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult ParticipantsCompletedNCT04095286Phase 1Results posted
- Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes ZosterCompletedNCT04091451Phase 3Results posted
- Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple MyelomaActive, not recruitingNCT04091126Phase 1Results posted
- A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older AdultsCompletedNCT04090658Phase 1Results posted
- Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents SubjectsCompletedNCT04079790Phase 1Results posted
- Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy SubjectsCompletedNCT04053023Phase 1Results posted
- Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority StudyCompletedNCT04052620Phase 3Results posted
- A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 WeeksCompletedNCT04050722Phase 4Results posted
- Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 YearsCompletedNCT04026009Phase 1Results posted
- Efficacy of Manual Toothbrushes in Removing Dental PlaqueCompletedNCT04025684Not applicableResults posted
- Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)CompletedNCT04021290Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)CompletedNCT04020341Phase 3Results posted
- 'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase InhibitorCompletedNCT04019873Results posted
- A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital GonorrheaCompletedNCT04010539Phase 3Results posted
- To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial ProductsCompletedNCT04007159Not applicableResults posted
- A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and LotionCompletedNCT04006795Not applicableResults posted
- Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)CompletedNCT04001803Phase 3Results posted
- Pharmacokinetics (PKs) and Metabolism of Radiolabelled LinerixibatCompletedNCT03992014Phase 1Results posted
- Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese DescentCompletedNCT03984838Phase 1Results posted
- Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral ContraceptiveCompletedNCT03984825Phase 1Results posted
- Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) StudyTerminatedNCT03984812Phase 1Results posted
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCompletedNCT03980483Phase 3Results posted
- A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic CoughTerminatedNCT03979638Phase 2Results posted
- Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United StatesCompletedNCT03973905Results posted
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)TerminatedNCT03970837Phase 3Results posted
- Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian SubjectsCompletedNCT03965533Phase 1Results posted
- Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian CancerTerminatedNCT03955471Phase 2Results posted
- Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 WeeksCompletedNCT03954743Phase 3Results posted
- Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected AdultsCompletedNCT03945981Phase 3Results posted
- Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin HypersensitivityCompletedNCT03943095Phase 2Results posted
- Dolutegravir Pediatric Liquid Formulation StudyCompletedNCT03921723Phase 1Results posted
- Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix VaccineCompletedNCT03894969Phase 2Results posted
- Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative ColitisTerminatedNCT03893565Phase 2Results posted
- Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy SubjectsTerminatedNCT03874234Phase 1Results posted
- Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B InfectionTerminatedNCT03866187Phase 1/2Results posted
- Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)CompletedNCT03848845Phase 1/2Results posted
- A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid TumorsTerminatedNCT03843359Phase 1Results posted
- Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/EmtricitabineCompletedNCT03836729Phase 1Results posted
- An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma TreatmentsCompletedNCT03828292Phase 1Results posted
- A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve AdultsCompletedNCT03824236Phase 2Results posted
- Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG)CompletedNCT03816696Phase 1Results posted
- A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older AdultsCompletedNCT03814590Phase 1/2Results posted
- Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy ParticipantsCompletedNCT03809910Phase 2Results posted
- To Evaluate Oral Health and Quality of Life Associated With Use of a Denture AdhesiveCompletedNCT03807700Phase 3Results posted
- To Evaluate the Effect of Moisturizing Creams on Skin Barrier FunctionCompletedNCT03804710Not applicableResults posted
- A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal VaccineCompletedNCT03803202Phase 1/2Results posted
- A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive AdultsCompletedNCT03784079Phase 2Results posted
- Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in GermanyCompletedNCT03754803Results posted